Delaware Mental Health Outpatient Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

The question that decides whether a Delaware outpatient mental health practice needs a facility license today comes down to one phrase in a DSAMH policy. DSAMH057, signed August 10, 2026, names “Mental health treatment practices” as a group that generally sits beyond the licensing reach of the Division of Substance Abuse and Mental Health (DSAMH). A program that “substantially engages in treating substance use disorder as a primary driver of the program” is a different story, and it needs one. That line holds for now. A law signed on August 31, 2026 ends that arrangement for many adult clinics, with a deadline of August 31, 2028 at the latest.

What Governs an Outpatient Practice Today

Taken from DSAMH’s August 2026 policy, the SUD licensing rule and Delaware’s counselor licensing statute.

Without a facility license, the regulation falls on the people. Counselors are licensed by the Board of Mental Health and Chemical Dependency Professionals, which issues the LPCMH, LACMH, LCDP and marriage and family therapy licenses under 24 Del. C. Chapter 30. An LPCMH applicant brings a master’s that includes 60 or more graduate semester hours of clinical mental health counseling, then 3,200 hours of experience gathered over no less than two and no more than four years, 1,600 of them supervised, and a passing score on the National Counselor Examination or another exam the Board accepts. The associate license, LACMH, lasts two years and “may be renewed up to 2 times.”

There is no Certificate of Public Review question for a practice either. Chapter 93 excludes physician offices from what it calls a “health-care facility,” and it excludes the offices of other licensed providers too, psychologists among them.

DSAMH also runs a Medicaid certification for adult behavioral health services. It’s a payer arrangement sitting outside any license, and it isn’t part of the work we do.

When Substance Use Becomes the “Primary Driver”

A practice crosses into DSAMH territory when addiction care becomes central to what it does, and the license then comes from 16 Del. Admin. Code 6001. Its section 4.1.1 requires any entity operating “a substance use treatment program or a co-occurring” program to be licensed for each program it runs. Section 16 of 6001 covers co-occurring treatment, with position qualifications for the Medical Director, the Clinical Director and a Qualified Psychiatric Practitioner, and 6001 defines that practitioner as a physician or nurse practitioner licensed in Delaware with “specific training in the use of buprenorphine and Opioid antagonist medications.”

One carve-out matters to psychiatric practices. Under DSAMH024, buprenorphine prescribing on its own does not trigger a DSAMH license, although the policy still expects a facility to “contact DSAMH prior to expanding services beyond MOUD treatment.” Licensing an outpatient SUD or co-occurring program is covered in Delaware Drug and Alcohol Outpatient Treatment Licensing.

How Chapter 56 Changes the Outpatient Picture

Statutory language is quoted from the new 16 Del. C. Chapter 56. Its effect on particular practice structures is our reading until DSAMH writes rules.

Senate Substitute 1 for Senate Bill 161 created Chapter 56 and, through a rewritten 29 Del. C. section 7908 that took effect immediately, gave DSAMH “The authority to create, implement, and oversee licensing requirements for all mental health treatment programs serving individuals who are 18 years old and older.” The licensing sections themselves begin no later than August 31, 2028, and earlier if DSAMH announces in the Register of Regulations that its final rules are adopted.

When they start, section 5602(b) says a person may not provide treatment services or operate a program “Except as otherwise provided under this chapter or with a valid license.” A “program” is “the treatment services delivered by a provider organization to treat a behavioral health condition.” Two exemptions in section 5602(a) are built for clinicians: “A licensed practitioner in private practice,” and “A licensed professional providing treatment services incidental to the professional’s regular practice.” Beyond those, the Director may exempt other organizations or services, but only on a finding that clients’ health, safety and welfare are not endangered.

Our reading is that a solo LPCMH keeps practicing without a facility license, while a group practice or clinic organized as a company and employing clinicians looks like a “provider organization” operating a “program” and should expect to apply. Where DSAMH draws the line between a private practice and a provider organization is the single most useful thing to watch for in its proposed rules.

A licensed organization will take on more than paperwork. Section 5604 forbids advertising “in a manner that is deceptive, false, misleading, or likely to intimidate or pressure an individual into accepting services” and soliciting “within 500 feet of another provider organization’s facility.” Subchapter V makes incident reporting an immediate duty of each staff member, and a staff member who intentionally skips reporting a critical incident commits a class A misdemeanor (section 5644). License fees will come later, by regulation, and section 5608(b) ties them to the Division’s own costs: the amount must “approximate and reasonably reflect the costs necessary to defray the Division’s expenses.”

Using the Next Two Years Well

A clinic that expects to need a DSAMH license can do most of the groundwork now. Write client-rights and incident procedures that would hold up in a licensing review. Keep supervision logs for associate clinicians current. Email DHSS_DSAMH_ProviderEnrollment@delaware.gov and ask DSAMH, in writing, whether your structure reads as a private practice or a program. And if any service line drifts toward substance use treatment, plan for a 6001 license now rather than in 2028.

Reporting Duties That Apply Right Now

Today’s outpatient practice still carries the general reporting law. Under 31 Del. C. section 3910, anyone, “including a health-care professional,” who has reasonable cause to think an adult is impaired, or is incapacitated and in need of protective services, must “report the information supporting reasonable cause to the Department.” The statute attaches no deadline to that general duty. DSAMH’s Community Incident Reporting Policy, DSAMH029, applies only to providers under contract with DSAMH, which report critical incidents within two business days.

Ketamine and Spravato in a Delaware Therapy or Psychiatry Office

No Delaware statute or rule addresses ketamine in a mental health practice. The conclusions below combine controlled substance law with DSAMH’s current licensing scope and are our interpretation.

Today, yes, and without a facility license, as long as the practice isn’t a substance use program. DSAMH’s licensing reaches SUD treatment, and we found no DHCQ license category for a ketamine clinic. What the practice does need is drug-control paperwork. Because 21 CFR 1308.13(c)(7) lists ketamine among Schedule III drugs, every prescriber needs DEA registration, and Delaware layers on a state controlled substance registration that is renewed biennially and needed again “at each principal place of business or professional practice” under 16 Del. C. section 4732. We could not pin down whether IV ketamine sedation would bring a site under DHCQ’s office-based surgery licensing, so ask DHCQ before buying infusion equipment.

The Prescription Monitoring Program treats the two common routes differently. Infusions given in the office stay out of it, because the state’s PMP guidance states that “The administration of a drug does not have to be reported to the PMP,” while any ketamine the practice dispenses must be reported, and dispensers report Schedule II through V drugs daily. Before prescribing a Schedule II through V drug, a prescriber must check the PMP when there is reason to believe the patient may be seeking it for a non-medical purpose (16 Del. C. section 4798). Spravato carries tighter federal limits. The FDA label allows it to be given only in settings certified under the drug’s REMS program, with the patient monitored on site for 2 hours or more after every dose.

Nurse practitioners can lead some of this work. The current nursing statute, 24 Del. C. section 1935(a)(1), says the Board of Nursing “grants full-practice and prescriptive authority upon the issuance of an APRN license,” and the older collaborative agreement section, 1936, now shows as repealed. We found no Board of Nursing position on RN-administered ketamine.

One caution about what’s coming. An entity-run ketamine clinic treating depression or PTSD is delivering treatment services for a behavioral health condition, so once Chapter 56 is implemented it may need a DSAMH license unless an exemption covers it. That question is open. Ownership options for a stand-alone clinic are explained in the ketamine discussion inside Delaware Drug and Alcohol Outpatient Treatment Licensing.

Staffing a Delaware Outpatient Mental Health Practice

The going rate is the place to start. BLS reports a median of $56,020 for Delaware’s substance abuse, behavioral disorder and mental health counselors (OEWS, May 2025), and the middle 50 percent earned from $43,760 to $64,790, compared with a national median of $59,350. A practice with three full-time therapists paid at the Delaware median carries about $168,060 in base salary before benefits, supervision time or a prescriber. Delaware’s associate license makes that easier to carry than it looks. An LACMH can practice for up to six years across its renewals while working off the supervised hours, 1,600 of them, that the LPCMH asks for, so a practice led by an experienced LPCMH supervisor can hire associates at wages below the median and give them the hours they need, a setup that can trim therapist payroll by 40 to 60 percent next to a staff made up entirely of LPCMHs. If ketamine is on the menu, an RN who supervises a couple of LPNs covers the monitoring chairs for less than an all-RN staff. We put numbers to the roster once the service mix is clear.

Where Delaware Outpatient Openings Stall

Two things tend to catch outpatient owners. One is seeing Chapter 22 listed online as repealed effective August 31, 2026 and assuming the new licensing regime is already in force, when section 12 of the Act delays it. The other is a therapy practice that adds intensive substance use groups without realizing it has crossed DSAMH’s “primary driver” line and now needs a 6001 license.

Frequently Asked Questions

Unsure where your Delaware practice will land under Chapter 56? Send us a note about it.

Sources

• DSAMH057, SUD Treatment Licensure and Certification Guidelines (signed August 10, 2026): DSAMH057 (PDF) (checked October 14, 2026)
• 16 Del. Admin. Code 6001, Substance Abuse Facility Licensing Standards (DSAMH-posted copy): 6001 (PDF) (checked October 14, 2026)
• DSAMH024, Buprenorphine Prescribing Practitioners Policy: DSAMH024 (PDF) (checked October 14, 2026)
• Division of Professional Regulation, Board of Mental Health and Chemical Dependency Professionals: Board page (checked October 14, 2026)
• 24 Del. C. Chapter 30, Board of Mental Health and Chemical Dependency Professionals: Chapter 30 (checked October 14, 2026)
• 24 Del. C. Chapter 30, Subchapter II, sections 3032 and 3033 (LPCMH and LACMH): Subchapter II (checked October 14, 2026)
• 16 Del. C. Chapter 93, Certificate of Public Review (sections 9302, 9304, 9305): Chapter 93 (checked October 14, 2026)
• DSAMH, Provider Policies and Resources: Provider Policies and Resources (checked October 14, 2026)
• Delaware General Assembly, Senate Substitute 1 for Senate Bill 161 (signed August 31, 2026, 85 Del. Laws c. 461): Bill detail and status (checked October 14, 2026)
• SS 1 for SB 161, enrolled text, Sections 6, 8, 9, 10, 11 and 12: Bill text (checked October 14, 2026)
• 16 Del. C. Chapter 56, Subchapter I (sections 5601 to 5608: definitions, license required, exemptions, penalties, fees): Subchapter I (checked October 14, 2026)
• 16 Del. C. Chapter 56, Subchapter V (sections 5641 to 5648: incidents and reports): Subchapter V (checked October 14, 2026)
• 31 Del. C. section 3910, via Justia (verbatim mirror): Adult protective services reporting (checked October 14, 2026)
• DSAMH029, Community Incident Reporting Policy (rev. October 2, 2024): DSAMH029 (PDF) (checked October 14, 2026)
• 21 CFR 1308.13(c)(7), via Cornell LII: Ketamine in Schedule III (checked October 14, 2026)
• 16 Del. C. section 4732 (controlled substance registration): Chapter 47, Subchapter III (checked October 14, 2026)
• Division of Professional Regulation, Prescription Monitoring Program FAQs: PMP FAQs (checked October 14, 2026)
• 16 Del. C. section 4798, via Justia (verbatim mirror): Prescription Monitoring Program (checked October 14, 2026)
• U.S. FDA, Spravato prescribing information and Medication Guide: Spravato label (PDF) (checked October 14, 2026)
• 24 Del. C. Chapter 19, section 1935 (APRN full-practice authority) and section 1936 (repealed): Chapter 19, Nursing (checked October 14, 2026)
• 16 Del. C. Chapter 22, Substance Abuse Treatment Act (repeal note): Chapter 22 (checked October 14, 2026)
• U.S. Bureau of Labor Statistics, OEWS May 2025, Delaware (SOC 21-1018): Delaware May 2025 estimates (checked October 14, 2026)
• U.S. Bureau of Labor Statistics, OEWS May 2025, national estimates (SOC 21-1018): National May 2025 estimates (checked October 14, 2026)